Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2021
|
P Roy Vagelos Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,861
+0.58%
|
-
|
|
Dec 08
2021
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Grant, award, or other acquisition
|
Direct |
4,344
+12.2%
|
-
|
|
Dec 08
2021
|
Robert E Landry EVP Finance CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,971
+11.7%
|
-
|
|
Dec 08
2021
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
3,462
+5.53%
|
-
|
|
Dec 03
2021
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
50,352
-49.7%
|
$31,822,464
$632.45 P/Share
|
|
Dec 03
2021
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
72,500
+41.71%
|
$12,977,500
$179.13 P/Share
|
|
Dec 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$639,000
$639.13 P/Share
|
|
Dec 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Dec 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$63,600
$636.48 P/Share
|
|
Nov 29
2021
|
Neil Stahl EVP Research and Development |
BUY
Bona fide gift
|
Indirect |
4,605
+50.0%
|
-
|
|
Nov 29
2021
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
4,605
-13.78%
|
-
|
|
Nov 22
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.19%
|
$1,314,000
$657.5 P/Share
|
|
Nov 19
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
1,000
-3.04%
|
$655,000
$655.0 P/Share
|
|
Nov 19
2021
|
Leonard S Schleifer President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
359,137
-30.2%
|
$233,798,187
$651.96 P/Share
|
|
Nov 19
2021
|
Leonard S Schleifer President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
520,313
+30.34%
|
$116,550,112
$224.78 P/Share
|
|
Nov 18
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
4,000
-10.85%
|
$2,600,000
$650.0 P/Share
|
|
Nov 17
2021
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
681
-2.55%
|
$439,245
$645.08 P/Share
|
|
Nov 16
2021
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
500
-2.17%
|
-
|
|
Nov 16
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
750
-42.86%
|
$487,500
$650.0 P/Share
|
|
Nov 16
2021
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
6,000
-4.9%
|
$3,936,000
$656.26 P/Share
|
|
Nov 16
2021
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,069
-10.32%
|
$1,997,919
$651.97 P/Share
|
|
Nov 16
2021
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+11.2%
|
$1,496,250
$399.66 P/Share
|
|
Nov 16
2021
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Open market or private sale
|
Direct |
6,778
-2.74%
|
$4,446,368
$656.32 P/Share
|
|
Nov 16
2021
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
7,167
-0.71%
|
$4,665,717
$651.16 P/Share
|
|
Nov 15
2021
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Payment of exercise price or tax liability
|
Direct |
18,222
-35.09%
|
$11,680,302
$641.5 P/Share
|
|
Nov 15
2021
|
Daniel P Van Plew EVP & General Mgr Industrial O |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+32.5%
|
$6,750,000
$270.43 P/Share
|
|
Nov 15
2021
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
9,412
-13.02%
|
$6,033,092
$641.5 P/Share
|
|
Nov 15
2021
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
16,579
+18.66%
|
$862,108
$52.03 P/Share
|
|
Nov 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$640,000
$640.0 P/Share
|
|
Nov 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Nov 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$64,200
$642.92 P/Share
|
|
Oct 04
2021
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
347
-0.24%
|
-
|
|
Oct 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$576,000
$576.75 P/Share
|
|
Oct 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Oct 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$56,900
$569.44 P/Share
|
|
Sep 15
2021
|
N Anthony Coles Director |
SELL
Open market or private sale
|
Direct |
11,948
-15.95%
|
$7,861,784
$658.26 P/Share
|
|
Sep 15
2021
|
N Anthony Coles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,948
+37.55%
|
$4,337,124
$363.21 P/Share
|
|
Sep 14
2021
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
998
-52.83%
|
$648,700
$650.0 P/Share
|
|
Sep 14
2021
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
998
+34.57%
|
$390,218
$391.92 P/Share
|
|
Sep 13
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
12,750
-10.7%
|
$8,211,000
$644.43 P/Share
|
|
Sep 13
2021
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,750
+30.37%
|
$3,480,750
$273.67 P/Share
|
|
Sep 13
2021
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
2
-0.22%
|
$1,302
$651.1 P/Share
|
|
Sep 13
2021
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2
+0.22%
|
$782
$391.92 P/Share
|
|
Sep 13
2021
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
9,704
-9.5%
|
$6,249,376
$644.47 P/Share
|
|
Sep 13
2021
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,704
+33.97%
|
$3,901,008
$402.54 P/Share
|
|
Sep 10
2021
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,479
-29.62%
|
$1,611,350
$650.0 P/Share
|
|
Sep 10
2021
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,479
+22.85%
|
$942,020
$380.95 P/Share
|
|
Sep 01
2021
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-5.54%
|
$674,000
$674.72 P/Share
|
|
Sep 01
2021
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.25%
|
$342,000
$342.93 P/Share
|
|
Sep 01
2021
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$67,800
$678.55 P/Share
|